- Home
- BRID vs MNOV Comparison
BRID vs MNOV Comparison
Compare BRID & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRID
- MNOV
- Stock Information
- Founded
- BRID 1932
- MNOV 2000
- Country
- BRID United States
- MNOV United States
- Employees
- BRID N/A
- MNOV N/A
- Industry
- BRID Specialty Foods
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- BRID Consumer Staples
- MNOV Health Care
- Exchange
- BRID Nasdaq
- MNOV Nasdaq
- Market Cap
- BRID 70.3M
- MNOV 68.2M
- IPO Year
- BRID N/A
- MNOV 2005
- Fundamental
- Price
- BRID $7.69
- MNOV $1.23
- Analyst Decision
- BRID
- MNOV Strong Buy
- Analyst Count
- BRID 0
- MNOV 2
- Target Price
- BRID N/A
- MNOV $7.00
- AVG Volume (30 Days)
- BRID 6.3K
- MNOV 20.6K
- Earning Date
- BRID 08-22-2025
- MNOV 08-07-2025
- Dividend Yield
- BRID N/A
- MNOV N/A
- EPS Growth
- BRID N/A
- MNOV N/A
- EPS
- BRID N/A
- MNOV N/A
- Revenue
- BRID $224,673,000.00
- MNOV N/A
- Revenue This Year
- BRID N/A
- MNOV N/A
- Revenue Next Year
- BRID N/A
- MNOV N/A
- P/E Ratio
- BRID N/A
- MNOV N/A
- Revenue Growth
- BRID N/A
- MNOV N/A
- 52 Week Low
- BRID $7.35
- MNOV $1.12
- 52 Week High
- BRID $14.69
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- BRID 41.24
- MNOV 40.69
- Support Level
- BRID $7.54
- MNOV $1.32
- Resistance Level
- BRID $8.74
- MNOV $1.38
- Average True Range (ATR)
- BRID 0.26
- MNOV 0.04
- MACD
- BRID -0.03
- MNOV 0.00
- Stochastic Oscillator
- BRID 2.42
- MNOV 36.87
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.